Article Dans Une Revue European Journal of Cancer Année : 2024

Cancer immunotherapy in elderly patients: the concept of immune senescence challenged by clinical experience

Résumé

Cancer immunotherapy, including immune checkpoint inhibitors, chimeric antigen receptor T-cell therapy and bispecific antibodies, has led to major improvements in the treatment of a wide range of hematologic malignancies and solid tumors. However, age-mediated immune system modifications, known as immunosenescence, may preclude its efficacy in elderly patients. In this review, we assessed the efficacy of these different cancer immunotherapies in elderly patients compared to young patients to revisit the concept of immunosenescence from a therapeutic perspective.
Fichier sous embargo
Fichier sous embargo
0 4 1
Année Mois Jours
Avant la publication
vendredi 23 mai 2025
Fichier sous embargo
vendredi 23 mai 2025
Connectez-vous pour demander l'accès au fichier

Dates et versions

hal-04891566 , version 1 (20-01-2025)

Licence

Identifiants

Citer

Mathilde Guégan, Malvina Bichon, Nathalie Chaput, Roch Houot, Jean Lemoine. Cancer immunotherapy in elderly patients: the concept of immune senescence challenged by clinical experience. European Journal of Cancer, 2024, 214, pp.115145-115145. ⟨10.1016/j.ejca.2024.115145⟩. ⟨hal-04891566⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More